Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

November 01, 2002; Volume 30,Issue 11

Short Communications

  • You have access
    Docetaxel (Taxotere) Is Not Metabolized by Recombinant Human CYP1B1 in Vitro, but Acts as an Effector of This Isozyme.
    Bruno Bournique and Audrey Lemarié
    Drug Metabolism and Disposition November 2002, 30 (11) 1149-1152; DOI: https://doi.org/10.1124/dmd.30.11.1149
  • You have access
    Inhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones
    James M. Mathews, Amy S. Etheridge and Sherry R. Black
    Drug Metabolism and Disposition November 2002, 30 (11) 1153-1157; DOI: https://doi.org/10.1124/dmd.30.11.1153

Articles

  • You have access
    Liver-Specific Distribution of Rosuvastatin in Rats: Comparison with Pravastatin and Simvastatin
    Ken-ichi Nezasa, Kazutaka Higaki, Tadahiko Matsumura, Kazuhiro Inazawa, Hiroshi Hasegawa, Masayuki Nakano and Masahiro Koike
    Drug Metabolism and Disposition November 2002, 30 (11) 1158-1163; DOI: https://doi.org/10.1124/dmd.30.11.1158
  • You have access
    Interaction of Ritonavir on Tissue Distribution of a [14C]L-Valinamide, a Potent Human Immunodeficiency Virus-1 Protease Inhibitor, in Rats Using Quantitative Whole-Body Autoradiography
    Eric G. Solon, Suresh K. Balani, Gang Luo, Tian J. Yang, Paula J. Haines, Lifei Wang, Tonya Demond, Sharon Diamond, David D. Christ, Liang-Shang Gan and Frank W. Lee
    Drug Metabolism and Disposition November 2002, 30 (11) 1164-1169; DOI: https://doi.org/10.1124/dmd.30.11.1164
  • You have access
    Pathways of Carbamazepine Bioactivation in Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-Hydroxylated Metabolites
    Robin E. Pearce, Gangadhara R. Vakkalagadda and J. Steven Leeder
    Drug Metabolism and Disposition November 2002, 30 (11) 1170-1179; DOI: https://doi.org/10.1124/dmd.30.11.1170
  • You have access
    Metabolism of Bisphenol A in Primary Cultured Hepatocytes from Mice, Rats, and Humans
    J. J. Pritchett, R. K. Kuester and I. G. Sipes
    Drug Metabolism and Disposition November 2002, 30 (11) 1180-1185; DOI: https://doi.org/10.1124/dmd.30.11.1180
  • You have access
    Down-Regulation of Alpha Class GlutathioneS-Transferase by Interleukin-1β in Human Intestinal Epithelial Cells (Caco-2) in Culture
    Laura Romero, Marnie A. Higgins, James Gilmore, Kim Boudreau, Ann Maslen, Heather J. Barker and Gordon M. Kirby
    Drug Metabolism and Disposition November 2002, 30 (11) 1186-1193; DOI: https://doi.org/10.1124/dmd.30.11.1186
  • You have access
    Activation of CYP2C9-Mediated Metabolism by a Series of Dapsone Analogs: Kinetics and Structural Requirements
    J. Matthew Hutzler, Dhanashri Kolwankar, Matthew A. Hummel and Timothy S. Tracy
    Drug Metabolism and Disposition November 2002, 30 (11) 1194-1200; DOI: https://doi.org/10.1124/dmd.30.11.1194
  • You have access
    Effects of G169R and P34S Substitutions Produced by Mutations ofCYP2D6*14 on the Functional Properties of CYP2D6 Expressed in V79 Cells
    Tomoko Shiraishi, Masakiyo Hosokawa, Kaoru Kobayashi, Hitoshi Tainaka, Yoshiyuki Yamaura, Miwo Taguchi and Kan Chiba
    Drug Metabolism and Disposition November 2002, 30 (11) 1201-1205; DOI: https://doi.org/10.1124/dmd.30.11.1201
  • You have access
    In Vivo and in Vitro Induction of Cytochrome P450 Enzymes in Beagle Dogs
    Richard A. Graham, April Downey, Dan Mudra, Linda Krueger, Kathy Carroll, Christopher Chengelis, Ajay Madan and Andrew Parkinson
    Drug Metabolism and Disposition November 2002, 30 (11) 1206-1213; DOI: https://doi.org/10.1124/dmd.30.11.1206
  • You have access
    Mechanism of the Reduced Elimination Clearance of Benzylpenicillin from Cerebrospinal Fluid in Rats with Intracisternal Administration of Lipopolysaccharide
    Hee Han, Sang-Geon Kim, Myung-Gull Lee, Chang-Koo Shim and Suk-Jae Chung
    Drug Metabolism and Disposition November 2002, 30 (11) 1214-1220; DOI: https://doi.org/10.1124/dmd.30.11.1214
  • You have access
    Metabolism of Capecitabine, an Oral Fluorouracil Prodrug:19F NMR Studies in Animal Models and Human Urine
    Franck Desmoulin, Véronique Gilard, Myriam Malet-Martino and Robert Martino
    Drug Metabolism and Disposition November 2002, 30 (11) 1221-1229; DOI: https://doi.org/10.1124/dmd.30.11.1221
  • You have access
    Fenbendazole Pharmacokinetics, Metabolism, and Potentiation in Horses
    Q. A. McKellar, C. Gokbulut, K. Muzandu and H. Benchaoui
    Drug Metabolism and Disposition November 2002, 30 (11) 1230-1239; DOI: https://doi.org/10.1124/dmd.30.11.1230
  • You have access
    Involvement of CYP2J2 on the Intestinal First-Pass Metabolism of Antihistamine Drug, Astemizole
    Shigeki Matsumoto, Tomoe Hirama, Tsutomu Matsubara, Kiyoshi Nagata and Yasushi Yamazoe
    Drug Metabolism and Disposition November 2002, 30 (11) 1240-1245; DOI: https://doi.org/10.1124/dmd.30.11.1240
  • You have access
    Contribution of Presystemic Hepatic Extraction to the Low Oral Bioavailability of Green Tea Catechins in Rats
    Yan Cai, Nathan D. Anavy and H-H. Sherry Chow
    Drug Metabolism and Disposition November 2002, 30 (11) 1246-1249; DOI: https://doi.org/10.1124/dmd.30.11.1246
  • You have access
    Involvement of Multiple UDP-glucuronosyltransferase 1A Isoforms in Glucuronidation of 5-(4′-hydroxyphenyl)-5-phenylhydantoin in Human Liver Microsomes
    Miki Nakajima, Nozomi Sakata, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
    Drug Metabolism and Disposition November 2002, 30 (11) 1250-1256; DOI: https://doi.org/10.1124/dmd.30.11.1250
  • You have access
    Stereoselective Conjugation of Oxazepam by Human UDP-Glucuronosyltransferases (UGTs): S-Oxazepam Is Glucuronidated by UGT2B15, While R-Oxazepam Is Glucuronidated by UGT2B7 and UGT1A9
    Michael H. Court, Su X. Duan, Chantal Guillemette, Kim Journault, Soundararajan Krishnaswamy, Lisa L. von Moltke and David J. Greenblatt
    Drug Metabolism and Disposition November 2002, 30 (11) 1257-1265; DOI: https://doi.org/10.1124/dmd.30.11.1257
  • You have access
    Differential Modulation of UDP-Glucuronosyltransferase 1A1 (UGT1A1)-Catalyzed Estradiol-3-glucuronidation by the Addition of UGT1A1 Substrates and Other Compounds to Human Liver Microsomes
    J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, Kristina Campanale, David R. Jones, Stephen D. Hall and Steven A. Wrighton
    Drug Metabolism and Disposition November 2002, 30 (11) 1266-1273; DOI: https://doi.org/10.1124/dmd.30.11.1266
  • You have access
    Biotransformation of Mirtazapine by Cunninghamella Elegans
    Joanna D. Moody, James P. Freeman, Peter P. Fu and Carl E. Cerniglia
    Drug Metabolism and Disposition November 2002, 30 (11) 1274-1279; DOI: https://doi.org/10.1124/dmd.30.11.1274
  • You have access
    Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
    Thomayant Prueksaritanont, Cuyue Tang, Yue Qiu, Lillian Mu, Raju Subramanian and Jiunn H. Lin
    Drug Metabolism and Disposition November 2002, 30 (11) 1280-1287; DOI: https://doi.org/10.1124/dmd.30.11.1280
  • You have access
    Structure and Stereochemistry of the Active Metabolite of Clopidogrel
    Jean-Marie Pereillo, Mohamed Maftouh, Alain Andrieu, Marie-Francoise Uzabiaga, Olivier Fedeli, Pierre Savi, Marc Pascal, Jean-Marc Herbert, Jean-Pierre Maffrand and Claudine Picard
    Drug Metabolism and Disposition November 2002, 30 (11) 1288-1295; DOI: https://doi.org/10.1124/dmd.30.11.1288

Erratum

  • You have access
    Correction to “The Multiple Indicator-Dilution Method for the Study of Enzyme Heterogeneity in Liver: Theoretical Basis”
    Drug Metabolism and Disposition November 2002, 30 (11) 1296;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 30 (11)
Drug Metabolism and Disposition
Vol. 30, Issue 11
1 Nov 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics